XLRN NASDAQ
Acceleron Pharma Inc.
1W: +3.3%
1M: +2.9%
3M: +42.9%
1Y: +61.1%
3Y: +247.6%
5Y: +368.6%
$178.75
Last traded 2021-11-19 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$113M
Revenue
+6.4% YoY
$-255M
Net Income
-92.8% YoY
$-267M
Free Cash Flow
-136.2% YoY
100.0%
Gross Margin
-206.5%
Op. Margin
-206.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-31.6%
ROA-29.4%
ROIC-136.7%
Valuation
P/E-61.2
P/B11.9
EV/EBITDA-39.6
Leverage
Debt/Equity0.03
Current Ratio12.14
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z88.42
Beneish M2.12